Evidence map›Paper›PMID 40925659›Full record

ArticleJournal of nuclear medicine technology2025

Availability of Radiopharmaceuticals and Imaging Equipment in English-Speaking African Countries.

Lerato S Mosima, Amanda E Manicum, Beverley Summers

Abstract read
In one paragraph

Article in Journal of nuclear medicine technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lerato S MosimaDepartment of Pharmaceutical Sciences, Sefako Makgatho Health Sciences University, Gauteng, South Africa; and lerato.mosima@smu.ac.za.
Amanda E ManicumDepartment of Chemistry, Tshwane University of Technology, Gauteng, South Africa.
Beverley SummersDepartment of Pharmaceutical Sciences, Sefako Makgatho Health Sciences University, Gauteng, South Africa; and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiopharmaceutical services are key in cancer screening, diagnosis, staging, treatment monitoring, detection of remission, and therapy. Unfortunately, due to the high costs of these services, their availability is very limited in developing countries. This study highlights issues related to access to radiopharmaceuticals and imaging equipment in English-speaking African countries.

Indexed as

Diagnostic ImagingHealth Services AccessibilityLanguageRadiopharmaceuticalsAfricaCross-Sectional StudiesHumansRadiopharmaceuticalsEnglish-speaking Africanoncommunicable diseasePETradiopharmaceuticalsSPECT

Identifiers

PMID40925659
PMCPMC12688044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.